Maltese Allelic Variants in Corneal Dystrophy Genes in a Worldwide Setting

Mol Diagn Ther. 2022 Sep;26(5):529-540. doi: 10.1007/s40291-022-00602-5. Epub 2022 Jul 7.

Abstract

Introduction: This study aimed to establish which worldwide population cohorts have a genetic make-up closest to that of a large sample of the Maltese population with regard to corneal dystrophy (CD) genes.

Methods: Single nucleotide polymorphisms (SNPs) in the Maltese cohort were compared with worldwide cohorts. Fixation index (FST) values were calculated to evaluate population differentiation. The genetic prevalence of CD subtypes in worldwide and Maltese cohorts were calculated, and single nucleotide missense mutations present in the Maltese cohort were evaluated for potential pathogenicity.

Results: FST values showed that CD-related genes differ substantially among the studied cohorts. FST values for each SNP showed greatest differentiation between the Maltese and African cohorts and least differentiation with the Puerto Rican, Mexican, and Colombian cohorts. One TGFBI casual CD mutation, 502V, which causes a Bowman's layer CD/atypical Thiel-Behnke CD was identified in the Maltese cohort. The KRT3 NC_000012.11:g.53186088G>C mutation was potentially deleterious.

Conclusion: Identifying populations with least genetic differentiation can facilitate and help guide future diagnostic and treatment strategies for Maltese individuals with CDs in the absence of comparable Maltese data. Analysing the previously unknown CD genetic pool present in a large Maltese cohort adds to the global genetic bank that researchers rely on for medical progress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Corneal Dystrophies, Hereditary* / diagnosis
  • Corneal Dystrophies, Hereditary* / genetics
  • Corneal Dystrophies, Hereditary* / surgery
  • Extracellular Matrix Proteins* / genetics
  • Humans
  • Mutation
  • Pedigree
  • Transforming Growth Factor beta / genetics

Substances

  • Extracellular Matrix Proteins
  • Transforming Growth Factor beta